Multiple sclerosis: TNF revisited, with promise
- 1 March 1995
- journal article
- editorial
- Published by Springer Nature in Nature Medicine
- Vol. 1 (3) , 211-214
- https://doi.org/10.1038/nm0395-211
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.The Journal of Experimental Medicine, 1995
- Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease.The Journal of Experimental Medicine, 1994
- Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor‐immunoglobulin fusion proteinsEuropean Journal of Immunology, 1994
- Interleukin‐10 prevents experimental allergic encephalomyelitis in ratsEuropean Journal of Immunology, 1994
- Anti—tumor necrosis factor therapy abrogates autoimmune demyelinationAnnals of Neurology, 1991
- An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis.The Journal of Experimental Medicine, 1990
- Tumor necrosis factor identified in multiple sclerosis brain.The Journal of Experimental Medicine, 1989
- Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitroAnnals of Neurology, 1988
- Proteinase inhibitors suppress the development of experimental allergic encephalomyelitisNature, 1980
- CYTOTOXICITY MEDIATED BY SOLUBLE ANTIGEN AND LYMPHOCYTES IN DELAYED HYPERSENSITIVITYThe Journal of Experimental Medicine, 1968